Pricing
Login
Home
Charts
Search
Watchlist
Products

Granules India Ltd

GRANULES
₹822.65+2.68%20 Nov 2026
Reports
Pharma Formulations

Granules India Ltd

GRANULES
₹822.65
+2.68%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹22,440Cr
Close
Close Price
₹822.65
Industry
Industry
Pharma Formulations
PE
Price To Earnings
28.47
PS
Price To Sales
3.81
Revenue
Revenue
₹5,895Cr
Rev Gr TTM
Revenue Growth TTM
21.75%
PAT Gr TTM
PAT Growth TTM
39.13%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,1561,1761,1809671,1381,1971,2101,2971,3881,4711,4771,560
Growth YoY
Revenue Growth YoY%
0.8-1.619.7-18.7-1.61.82.634.222.022.822.020.3
Expenses
ExpensesCr
9059209217639079459631,0191,0801,1191,1381,222
Operating Profit
Operating ProfitCr
250256259203230252247278308352339338
OPM
OPM%
21.721.822.021.020.221.120.421.422.223.922.921.6
Other Income
Other IncomeCr
1223633-10-1-425211
Interest Expense
Interest ExpenseCr
292927262724242929332121
Depreciation
DepreciationCr
525353535764697274828084
PBT
PBTCr
170176181128153198145176202262240243
Tax
TaxCr
444647313546324552616062
PAT
PATCr
12613013597118152113131150202180182
Growth YoY
PAT Growth YoY%
1.18.4181.1-4.8-6.417.3-16.434.327.732.659.839.2
NPM
NPM%
10.911.011.410.110.312.79.310.110.813.712.211.7
EPS
EPS₹
5.25.35.64.04.86.34.65.46.28.27.37.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,1561,1761,1809671,1381,1971,2101,2971,3881,4711,4771,560
Growth YoY
Revenue Growth YoY%
0.8-1.619.7-18.7-1.61.82.634.222.022.822.020.3
Expenses
ExpensesCr
9059209217639079459631,0191,0801,1191,1381,222
Operating Profit
Operating ProfitCr
250256259203230252247278308352339338
OPM
OPM%
21.721.822.021.020.221.120.421.422.223.922.921.6
Other Income
Other IncomeCr
1223633-10-1-425211
Interest Expense
Interest ExpenseCr
292927262724242929332121
Depreciation
DepreciationCr
525353535764697274828084
PBT
PBTCr
170176181128153198145176202262240243
Tax
TaxCr
444647313546324552616062
PAT
PATCr
12613013597118152113131150202180182
Growth YoY
PAT Growth YoY%
1.18.4181.1-4.8-6.417.3-16.434.327.732.659.839.2
NPM
NPM%
10.911.011.410.110.312.79.310.110.813.712.211.7
EPS
EPS₹
5.25.35.64.04.86.34.65.46.28.27.37.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,3571,4111,6852,2792,5993,2383,7654,5124,5064,4825,3665,895
Growth
Revenue Growth%
4.93.919.435.314.024.616.319.8-0.1-0.619.721.8
Expenses
ExpensesCr
1,0811,1121,4061,8952,0732,3823,0433,5983,6503,5364,1814,559
Operating Profit
Operating ProfitCr
2762992783845258557229148569451,1851,337
OPM
OPM%
20.421.216.516.920.226.419.220.319.021.122.122.7
Other Income
Other IncomeCr
5352775902718144441034
Interest Expense
Interest ExpenseCr
3732332827262356106103114103
Depreciation
DepreciationCr
587276105137151159184207226296319
PBT
PBTCr
186230196326451704558687547660785948
Tax
TaxCr
61656389116155145171142159190235
PAT
PATCr
125165133236335549413517405502595714
Growth
PAT Growth%
37.431.7-19.478.341.963.8-24.925.2-21.523.718.639.1
NPM
NPM%
9.211.77.910.412.917.011.011.49.011.211.112.1
EPS
EPS₹
6.07.55.59.313.222.116.721.116.720.724.528.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,3571,4111,6852,2792,5993,2383,7654,5124,5064,4825,3665,895
Growth
Revenue Growth%
4.93.919.435.314.024.616.319.8-0.1-0.619.721.8
Expenses
ExpensesCr
1,0811,1121,4061,8952,0732,3823,0433,5983,6503,5364,1814,559
Operating Profit
Operating ProfitCr
2762992783845258557229148569451,1851,337
OPM
OPM%
20.421.216.516.920.226.419.220.319.021.122.122.7
Other Income
Other IncomeCr
5352775902718144441034
Interest Expense
Interest ExpenseCr
3732332827262356106103114103
Depreciation
DepreciationCr
587276105137151159184207226296319
PBT
PBTCr
186230196326451704558687547660785948
Tax
TaxCr
61656389116155145171142159190235
PAT
PATCr
125165133236335549413517405502595714
Growth
PAT Growth%
37.431.7-19.478.341.963.8-24.925.2-21.523.718.639.1
NPM
NPM%
9.211.77.910.412.917.011.011.49.011.211.112.1
EPS
EPS₹
6.07.55.59.313.222.116.721.116.720.724.528.9
Sales CAGR
1 Year20%
3 Years6%
5 Years11%
TTM22%
EBITDA CAGR
1 Year25%
3 Years9%
5 Years7%
TTM33%
PAT CAGR
1 Year19%
3 Years5%
5 Years2%
TTM39%
Avg. ROCE
1 Year14%
3 Years15%
5 Years16%
TTM15%
CFO / EBITDA
1 Year67%
3 Years70%
5 Years69%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
222325252525252424242527
Reserves
ReservesCr
6138811,2791,5041,8182,1492,5622,8113,2013,6914,6956,539
Current Liabilities
Current LiabilitiesCr
6557878788968931,1731,6421,8142,0822,0032,0921,748
Non Current Liabilities
Non Current LiabilitiesCr
247188495557491367284256213534543557
Total Liabilities
Total LiabilitiesCr
1,5631,8792,6772,9833,2283,7134,5134,9055,5216,2537,7208,872
Current Assets
Current AssetsCr
8188281,1871,2821,6291,9972,5052,5742,9053,1153,7684,552
Non Current Assets
Non Current AssetsCr
7451,0511,4911,7011,6001,7162,0082,3302,6163,1373,9524,319
Total Assets
Total AssetsCr
1,5631,8792,6772,9833,2283,7134,5134,9055,5216,2537,7208,872
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
222325252525252424242527
Reserves
ReservesCr
6138811,2791,5041,8182,1492,5622,8113,2013,6914,6956,539
Current Liabilities
Current LiabilitiesCr
6557878788968931,1731,6421,8142,0822,0032,0921,748
Non Current Liabilities
Non Current LiabilitiesCr
247188495557491367284256213534543557
Total Liabilities
Total LiabilitiesCr
1,5631,8792,6772,9833,2283,7134,5134,9055,5216,2537,7208,872
Current Assets
Current AssetsCr
8188281,1871,2821,6291,9972,5052,5742,9053,1153,7684,552
Non Current Assets
Non Current AssetsCr
7451,0511,4911,7011,6001,7162,0082,3302,6163,1373,9524,319
Total Assets
Total AssetsCr
1,5631,8792,6772,9833,2283,7134,5134,9055,5216,2537,7208,872

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
151188-1262476432332739439867793
Investing Cash Flow
Investing Cash FlowCr
-162-326-462-270-161-277-380-191-360-691-773
Financing Cash Flow
Financing Cash FlowCr
8656529-17-213-299190-4408-93379
Net Cash Flow
Net Cash FlowCr
75-8266-25103-1441421078783399
Free Cash Flow
Free Cash FlowCr
-10-127-447-17292161-6532861297239
CFO To PAT
CFO To PAT%
121.3114.4-0.5110.9142.078.780.5143.0108.4172.8133.3
CFO To EBITDA
CFO To EBITDA%
54.863.0-0.268.390.750.646.080.851.391.766.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
151188-1262476432332739439867793
Investing Cash Flow
Investing Cash FlowCr
-162-326-462-270-161-277-380-191-360-691-773
Financing Cash Flow
Financing Cash FlowCr
8656529-17-213-299190-4408-93379
Net Cash Flow
Net Cash FlowCr
75-8266-25103-1441421078783399
Free Cash Flow
Free Cash FlowCr
-10-127-447-17292161-6532861297239
CFO To PAT
CFO To PAT%
121.3114.4-0.5110.9142.078.780.5143.0108.4172.8133.3
CFO To EBITDA
CFO To EBITDA%
54.863.0-0.268.390.750.646.080.851.391.766.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,5993,1692,6272,9063,6517,5127,5967,03710,42111,81415,39222,440
Price To Earnings
Price To Earnings
21.519.319.812.310.913.718.413.625.723.625.928.5
Price To Sales
Price To Sales
1.92.31.61.31.42.32.01.62.32.62.93.8
Price To Book
Price To Book
3.93.52.01.92.03.52.92.53.23.23.33.4
EV To EBITDA
EV To EBITDA
11.012.412.59.87.99.311.38.513.313.413.516.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
40.244.639.738.644.550.843.843.248.253.956.656.6
OPM
OPM%
20.421.216.516.920.226.419.220.319.021.122.122.7
NPM
NPM%
9.211.77.910.412.917.011.011.49.011.211.112.1
ROCE
ROCE%
18.417.410.114.418.125.016.119.214.414.814.414.6
ROE
ROE%
19.718.210.215.518.225.316.018.212.613.512.610.9
ROA
ROA%
8.08.85.07.910.414.89.210.57.38.07.78.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,5993,1692,6272,9063,6517,5127,5967,03710,42111,81415,39222,440
Price To Earnings
Price To Earnings
21.519.319.812.310.913.718.413.625.723.625.928.5
Price To Sales
Price To Sales
1.92.31.61.31.42.32.01.62.32.62.93.8
Price To Book
Price To Book
3.93.52.01.92.03.52.92.53.23.23.33.4
EV To EBITDA
EV To EBITDA
11.012.412.59.87.99.311.38.513.313.413.516.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
40.244.639.738.644.550.843.843.248.253.956.656.6
OPM
OPM%
20.421.216.516.920.226.419.220.319.021.122.122.7
NPM
NPM%
9.211.77.910.412.917.011.011.49.011.211.112.1
ROCE
ROCE%
18.417.410.114.418.125.016.119.214.414.814.414.6
ROE
ROE%
19.718.210.215.518.225.316.018.212.613.512.610.9
ROA
ROA%
8.08.85.07.910.414.89.210.57.38.07.78.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr38,67735,49928,45122,44020,46118,27515,974
Close PriceClose₹2,408.902,184.401,718.70822.651,040.951,317.20814.30
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE53.2286.5587.0728.4724.2525.6017.74
Price To SalesPS9.329.4613.553.812.415.495.17
RevenueRevenueCr4,1483,7512,1005,8958,4773,3303,089
Revenue Growth TTMRev Gr TTM%5.9%25.7%46.3%21.8%19.7%11.1%-29.6%
PAT Growth TTMPAT Gr TTM%7.6%894.1%89.4%39.1%32.9%60.0%-56.4%
Market CapitalizationMkt CapCr38,67735,49928,45122,44020,46118,27515,974
Close PriceClose₹2,408.902,184.401,718.70822.651,040.951,317.20814.30
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE53.2286.5587.0728.4724.2525.6017.74
Price To SalesPS9.329.4613.553.812.415.495.17
RevenueRevenueCr4,1483,7512,1005,8958,4773,3303,089
Revenue Growth TTMRev Gr TTM%5.9%25.7%46.3%21.8%19.7%11.1%-29.6%
PAT Growth TTMPAT Gr TTM%7.6%894.1%89.4%39.1%32.9%60.0%-56.4%
Interviews